Sunshine Biopharma
(NASDAQ) SBFMW
Sunshine Biopharma Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$35.49M
Net Income (TTM)
-$6.04M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
1.61 (High)
Dividend
$0.00
Beta (Volatility)
1.61 (High)
Price
$0.06
Volume
36,229
Open
$0.04
Price
$0.06
Volume
36,229
Open
$0.04
Previous Close
$0.04
Daily Range
$0.04 - $0.04
52-Week Range
$0.04 - $0.65
Estimated Earnings Date
Aug 5, 2026
Dividend
$0.00
Beta (Volatility)
1.61 (High)
Price
$0.06
Volume
36,229
Open
$0.04
Previous Close
$0.04
Daily Range
$0.04 - $0.04
52-Week Range
$0.04 - $0.65
Estimated Earnings Date
Aug 5, 2026
SBFMW News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Sunshine Biopharma
SBFMW Financials
Key Financial Metrics (TTM)
Gross Margin
32%
Operating Margin
-13%
Net Income Margin
-17%
Return on Equity
0%
Return on Capital
-21%
Return on Assets
-22%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
0
Volume
36.23K
Avg. Volume
6.82K
Financials (TTM)
Gross Profit
$11.92M
Operating Income
-$4.48M
EBITDA
-$4.15M
Operating Cash Flow
-$5.33M
Capital Expenditure
-$174.49K
Free Cash Flow
-$5.51M
Cash & ST Invst.
$9.12M
Total Debt
$812.42K
Sunshine Biopharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$8.09M
-9.1%
Gross Profit
$2.10M
-22.9%
Gross Margin
26.01%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
52
N/A
Net Income
-$1.24M
-5.4%
EBITDA
-$1.32M
-14.2%
Quarterly Fundamentals
Net Cash
$6.17M
-15.0%
Accounts Receivable
$4.01M
+16.4%
Inventory
$13.17M
+11.1%
Long Term Debt
$535.61K
-25.8%
Short Term Debt
$209.23K
-2.2%
Return on Assets
-21.62%
N/A
Return on Invested Capital
-20.76%
N/A
Free Cash Flow
-$2.08M
-7.9%
Operating Cash Flow
-$2.07M
-20.9%